Business Description
Zhongzhi Pharmaceutical Holdings Ltd
ISIN : KYG989611085
Total Employee Number:
2,284Compare
Compare
Traded in other countries / regions
03737.Hong Kong IPO Date
2015-07-13Description
Zhongzhi Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products in the PRC. The Group is a large industrial and trading enterprise group featuring researching, producing, and selling traditional Chinese medicine preparations, prepared slices of Chinese crude drugs, and foods. Its products include Shenqi Koufuye, Yinhuang Jiaonang, Yinhuang Keli, and others. Its segments are the pharmaceutical manufacturing segment, which generates maximum revenue, is engaged in the research and development, manufacturing, and sale of Chinese patent medicines and decoction pieces consisting of traditional decoction pieces and modern decoction pieces, and the operation of the chain pharmacies segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.77 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | 1.8 | |||||
Interest Coverage | 3.59 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.35 | |||||
Beneish M-Score | -2.87 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.1 | |||||
3-Year EBITDA Growth Rate | -18 | |||||
3-Year EPS without NRI Growth Rate | -43.9 | |||||
3-Year FCF Growth Rate | -9.1 | |||||
3-Year Book Growth Rate | 2.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 76.22 | |||||
9-Day RSI | 65.48 | |||||
14-Day RSI | 59.35 | |||||
3-1 Month Momentum % | -4.11 | |||||
6-1 Month Momentum % | -10.26 | |||||
12-1 Month Momentum % | -4.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.6 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 141.12 | |||||
Days Sales Outstanding | 67.41 | |||||
Days Payable | 85.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 2 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 9.02 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.44 | |||||
Operating Margin % | 1.11 | |||||
Net Margin % | 1 | |||||
EBITDA Margin % | 7.31 | |||||
FCF Margin % | 8.3 | |||||
OCF Margin % | 10.32 | |||||
ROE % | 1.59 | |||||
ROA % | 0.93 | |||||
ROIC % | 1.38 | |||||
3-Year ROIIC % | -79.48 | |||||
ROC (Joel Greenblatt) % | 2.72 | |||||
ROCE % | 2.01 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 32.27 | |||||
PE Ratio without NRI | 28.4 | |||||
Shiller PE Ratio | 5.46 | |||||
Price-to-Owner-Earnings | 5.08 | |||||
PS Ratio | 0.29 | |||||
PB Ratio | 0.5 | |||||
Price-to-Tangible-Book | 0.5 | |||||
Price-to-Free-Cash-Flow | 3.72 | |||||
Price-to-Operating-Cash-Flow | 2.97 | |||||
EV-to-EBIT | 24.15 | |||||
EV-to-EBITDA | 4.65 | |||||
EV-to-Revenue | 0.34 | |||||
EV-to-FCF | 4.1 | |||||
Price-to-GF-Value | 0.8 | |||||
Price-to-Projected-FCF | 0.39 | |||||
Price-to-Median-PS-Value | 0.47 | |||||
Price-to-Graham-Number | 0.8 | |||||
| Price-to-Net-Current-Asset-Value | 2.09 | |||||
Earnings Yield (Greenblatt) % | 4.14 | |||||
FCF Yield % | 26.45 | |||||
Forward Rate of Return (Yacktman) % | 1.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhongzhi Pharmaceutical Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,909.173 | ||
| EPS (TTM) (HK$) | 0.022 | ||
| Beta | 0.0217 | ||
| 3-Year Sharpe Ratio | -0.49 | ||
| 3-Year Sortino Ratio | -0.69 | ||
| Volatility % | 34.91 | ||
| 14-Day RSI | 59.35 | ||
| 14-Day ATR (HK$) | 0.050242 | ||
| 20-Day SMA (HK$) | 0.66625 | ||
| 12-1 Month Momentum % | -4.11 | ||
| 52-Week Range (HK$) | 0.5 - 0.98 | ||
| Shares Outstanding (Mil) | 843.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhongzhi Pharmaceutical Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhongzhi Pharmaceutical Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.050000 Cash Dividend | 2025-05-23 | 0.90 (+0.00%) |
Show
Entries
Zhongzhi Pharmaceutical Holdings Ltd Frequently Asked Questions
What is Zhongzhi Pharmaceutical Holdings Ltd(HKSE:03737)'s stock price today?
The current price of HKSE:03737 is HK$0.71. The 52 week high of HKSE:03737 is HK$0.98 and 52 week low is HK$0.50.
When is next earnings date of Zhongzhi Pharmaceutical Holdings Ltd(HKSE:03737)?
The next earnings date of Zhongzhi Pharmaceutical Holdings Ltd(HKSE:03737) is .
Does Zhongzhi Pharmaceutical Holdings Ltd(HKSE:03737) pay dividends? If so, how much?
Zhongzhi Pharmaceutical Holdings Ltd(HKSE:03737) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Zhongzhi Pharmaceutical Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers